| Display title | Chemistry:Chlorproethazine |
| Default sort key | Chlorproethazine |
| Page length (in bytes) | 5,213 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 806744 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Rtexter1 |
| Date of page creation | 08:20, 6 March 2023 |
| Latest editor | imported>Rtexter1 |
| Date of latest edit | 08:20, 6 March 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Chlorproethazine, sold under the brand name Neuriplege, is a drug of the phenothiazine group described as a muscle relaxant or tranquilizer which is or has been marketed in Europe as a topical cream for the treatment of muscle pain. It has been associated with photoallergic contact dermatitis. |
